Biora Therapeutics Inc
NASDAQ: BIOR · HEALTHCARE · BIOTECHNOLOGY
Updated 2026-04-30
Biora Therapeutics Inc (BIOR) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for BIOR.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
BIOR historical valuation range
Where current P/E sits in BIOR's own 5Y range.
BIOR intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
BIOR valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 0.61x
P/S Ratio — History
Current: 0.74x
Is BIOR overvalued in 2026?
Biora Therapeutics Inc (BIOR) currently trades at $0.22 per share with a market capitalization of $994,990.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 38/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 0.6x.
Our discounted cash flow model estimates BIOR's intrinsic value at $0.82 per share, against the current market price of $0.22. This implies a margin of safety of +73.17%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 0/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: BIOR appears richly valued on our framework, with a Smart Value Score of 38/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is BIOR overvalued in 2026?
Based on a Smart Value Score of 38/100, BIOR appears overvalued. Current price exceeds what fundamentals currently justify.
What is BIOR's fair value?
Our DCF model estimates BIOR's intrinsic value at $0.82 per share, versus the current price of $0.22. This produces a margin of safety of +73.17%.
What P/E ratio does BIOR trade at?
BIOR trades at a P/E of 0.6x on trailing twelve-month earnings.
Is BIOR a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 38/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does BIOR's valuation compare to its history?
Insufficient historical valuation data exists yet for a confident percentile read on BIOR.
What is BIOR's Smart Value Score?
BIOR's Smart Value Score is 38/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.